v3.25.2
LONG-TERM DEBT (Tables)
 12 Months Ended
Aug. 02, 2025
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
The Company’s long-term debt consisted of the following:
(in millions)
Average Interest Rate at
August 2, 2025
Fiscal Maturity YearAugust 2, 2025August 3, 2024
Term Loan Facility (1)
9.11%2031$383 $499 
ABL Credit Facility (2)
5.79%2027999 1,113 
Senior Notes (3)
6.75%2029500 500 
Other secured loans—%2025— 1 
Debt issuance costs, net(13)(18)
Original issue discount on debt(7)(10)
Long-term debt, including current portion1,862 2,085 
Less: current portion of long-term debt(3)(4)
Long-term debt$1,859 $2,081 
(1) Face value before debt issuance costs of $4 million and $6 million, respectively and an original issue discount on debt of $7 million and $10 million, respectively.
(2) Face value before debt issuance costs of $5 million and $7 million, respectively.
(3) Face value before debt issuance costs of $4 million and $5 million, respectively.
Schedule of Maturities of Long-term Debt
Future maturities of long-term debt, excluding debt issuance costs and original issue and purchase accounting discounts on debt, and contractual interest payments based on the face value and applicable interest rate as of August 2, 2025, consist of the following (in millions):
Fiscal YearLong-term debt maturityInterest on long-term debt
2026$5 $127 
20271,004 118 
20285 68 
2029505 51 
20305 34 
2031 and thereafter358 24 
$1,882 $422 
Schedule of Line of Credit Facilities and were as follows:
Range of Facility Rates and Fees (per annum)August 2, 2025
Applicable margin for revolver base rate loans
0.00% - 0.25%
0.00 %
Applicable margin for revolver SOFR and BA loans(1)
1.00% - 1.25%
1.00 %
Applicable margin for FILO base rate loans
1.50%
1.50 %
Applicable margin for FILO SOFR loans
2.50%
2.50 %
Unutilized commitment fees
0.20%
0.20 %
Letter of credit fees
1.125% - 1.375%
1.125 %
(1) The Company utilizes SOFR-based loans and UNFI Canada utilizes bankers’ acceptance rate-based loans.
The assets included in the Consolidated Balance Sheets securing the outstanding obligations under the ABL Credit Facility on a first-priority basis were as follows:
(in millions)August 2, 2025August 3, 2024
Certain inventory assets included in Inventories, net $1,830 $1,915 
Certain receivables included in Accounts receivable, net 780 611 
Pharmacy prescription files included in Intangible assets, net1 6 
Total $2,611 $2,532 
The Company’s unused credit under the ABL Credit Facility was as follows:
(in millions)August 2, 2025
Total availability for ABL loans and letters of credit$2,636 
ABL loans outstanding999 
Letters of credit outstanding184 
Unused credit$1,453